The divide between clinical need and actual prescription uptake represents one of the starkest inequities in modern preventative medicine. While roughly three-quarters of white individuals with indications for PrEP receive a prescription, fewer than a quarter of eligible Hispanic and Latino individuals obtain one.
| Demographic Group | Estimated PrEP Coverage (2020) | Estimated PrEP Coverage (2025, 2026) | Primary Systemic Barrier |
|---|---|---|---|
| White Sexual Minority Men | 65%, 70% | 78%, 84% | Routine clinical adherence fatigue |
| Latino Gay Men | 16%, 20% | 26%, 31% | Uninsured rates and language access |
| Bisexual Latino Men | 8%, 12% | 14%, 18% | Cultural stigma and provider non-disclosure |
| Black Sexual Minority Men | 9%, 13% | 18%, 22% | Medical mistrust and regional clinic deserts |
Even with generic emtricitabine/tenofovir available at steep discounts, secondary costs continue to lock patients out. PrEP requires quarterly kidney function panels, liver screenings, and comprehensive STI testing. For an uninsured worker paying out of pocket, laboratory bills can run between $400 and $800 each visit. If a clinic lacks Title X or Section 330 community health center funding, the preventive regimen becomes financially impossible.
